{"altmetric_id":2936881,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["130041937149457"],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"The gamma-aminobutyric acid type B-receptor agonist lesogaberan (AZD3355) has been developed for use in patients with gastroesophageal reflux disease (GERD) symptoms despite proton pump inhibitor (PPI) therapy (partial responders). This study aimed to explore the dose-response effect of lesogaberan on reflux episodes in partial responders.","abstract_source":"pubmed","altmetric_jid":"4f6fa4d03cf058f6100007b7","doi":"10.1186\/1471-230x-14-188","first_seen_on":"2014-11-30T17:15:14+00:00","funders":["niehs"],"issns":["1471-230X"],"issue":"1","journal":"BMC Gastroenterology","last_mentioned_on":1417367691,"links":["http:\/\/www.biomedcentral.com\/1471-230X\/14\/188\/abstract"],"pdf_url":"http:\/\/www.biomedcentral.com\/content\/pdf\/1471-230X-14-188.pdf","pmid":"25407279","pubdate":"2014-11-18T00:00:00+00:00","publisher":"BioMed Central Ltd","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"188","subjects":["gastroenterology"],"title":"Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study","type":"article","volume":"14","mendeley_url":"http:\/\/www.mendeley.com\/research\/dosedependent-effects-lesogaberan-reflux-measures-patients-refractory-gastroesophageal-reflux-diseas"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4565650,"mean":5.3760928148882,"rank":3699923,"this_scored_higher_than_pct":3,"this_scored_higher_than":140934,"rank_type":"exact","sample_size":4565650,"percentile":3},"similar_age_3m":{"total_number_of_other_articles":146340,"mean":8.2520447727537,"rank":114789,"this_scored_higher_than_pct":1,"this_scored_higher_than":1473,"rank_type":"exact","sample_size":146340,"percentile":1},"this_journal":{"total_number_of_other_articles":559,"mean":2.7678172043011,"rank":471,"this_scored_higher_than_pct":1,"this_scored_higher_than":7,"rank_type":"exact","sample_size":559,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":20,"mean":8.2889473684211,"rank":18,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":20,"percentile":1}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Ph. D. Student":1},"by_discipline":{"Agricultural and Biological Sciences":1}}}},"posts":{"facebook":[{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/130041937149457\/posts\/402177953269186","license":"public","citation_ids":[2936881],"posted_on":"2014-11-30T17:14:51+00:00","summary":"New Reflux Medication by AstraZeneca given a thumbs up in trial http:\/\/www.biomedcentral.com\/1471-230X\/14\/188\/abstract","author":{"name":"DLH Foundation -  For Gastro-esophageal cancers","url":"https:\/\/www.facebook.com\/130041937149457","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/130041937149457\/picture","id_on_source":"130041937149457"}}]}}